Genome instability is the main risk factor in the development of tumours in humans. Understanding how, where, when and why these mutations are produced in DNA is one of the great objectives of the global scientific community. Therefore, a group of experts from the University of Seville and the Andalusian Center for Molecular Biology and Regenerative Medicine (Cabimer) has published a study that indicates a new element involved in this process: chromatin.